Trump reclassifies cannabis in the USA and recognizes medicinal use at the federal level; Check out the analysis
Move from Schedule I to Schedule III could unlock research, ease fiscal obstacles, and impact state markets
The President of the United States, Donald Trump, signed an executive order this week reclassifying cannabis from Schedule I to Schedule III of the Controlled Substances Act. The decision changes the federal status of the plant, officially recognizes its medicinal potential, and directs the government to advance studies to include CBD-based treatments in Medicare coverage, a federal health program for the elderly and disabled.
End of the most restrictive classification
With the reclassification, cannabis is no longer considered a substance